Jump to content

PubMed RSS Feed - -Pityriasis Folliculorum: Response to Topical Ivermectin.


rss

Recommended Posts

Pityriasis Folliculorum: Response to Topical Ivermectin.

J Drugs Dermatol. 2017 Dec 01;16(12):1290-1292

Authors: Darji K, Burkemper NM

Abstract
<p>Pityriasis folliculorum has been described as a dry type of rosacea with extensive proliferation of Demodex folliculorum in pilosebaceous follicles of the skin. This skin condition is frequently difficult to manage, with various treatment options showing mixed efficacy. Oral ivermectin, a macrocyclic lactone parasiticide with anti-inflammatory and anti-parasitic effects, is one of the leading treatment modalities for demodicosis. Topical ivermectin has recently been FDA approved as therapy for rosacea. We present the case of a woman with pityriasis folliculorum who showed significant improvement from using topical ivermectin with no adverse events related to treatment.</p> <p><em>J Drugs Dermatol. 2017;16(12):1290-1292.</em></p>.

PMID: 29240866 [PubMed - in process]

{url} = URL to article

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...